Cytoreduction and Stem Cell Mobilization with a Regimen of Paclitaxel, Etoposide and Cyclophosphamide Followed by Autologous Transplantation Using a Preparative Regimen of Busulfan, Etoposide and Cyclophosphamide for Patients with Advanced Lymphoma

Publisher： Karger

E-ISSN： 1421-9662|105|4|222-232

ISSN： 0001-5792

Source： Acta Haematologica, Vol.105, Iss.4, 2001-08, pp. : 222-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Pilot Study of Busulfan, Cyclophosphamide and Etoposide Followed by Autologous Transplantation for Acute Myeloid Leukemia in Remission

By  

Acta Haematologica, Vol. 104, Iss. 2-3, 2001-01 ,pp. : 144-147

Karger

Access to resources Recommend Favorite

Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B‐cell lymphoma not eligible for autologous stem cell transplantation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 663-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Asymptomatic Cardiac Metastasis and Successful Salvage Chemotherapy Comprising a Prednisone, Etoposide, Procarbazine, and Cyclophosphamide Regimen in an Elderly Japanese Patient Suffering from a Delayed Recurrence of Diffuse Large B-Cell Lymphoma

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-01 ,pp. : 62-68

Karger

Access to resources Recommend Favorite

Cyclophosphamide‐based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 3, 2015-06 ,pp. : 176-182

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Three Cytokine Regimens on Hematologic Recovery and Progenitor Cell Mobilization after High-Dose Cyclophosphamide, Etoposide, and Cisplatin

By  

Oncology, Vol. 59, Iss. 1, 2000-06 ,pp. : 7-13

Karger

Access to resources Recommend Favorite